As Congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients’ share of the cost of insulin.
(Image credit: Picture Alliance/Getty Image)
As Congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients’ share of the cost of insulin.
(Image credit: Picture Alliance/Getty Image)